The Third Transatlantic Exchange in Oncology: Liquid Biopsy as an Emerging Approach in Precision Cancer Medicine

OVERVIEW

With genomic and protein biomarker analysis now a cornerstone of personalized cancer care, translational advancements and novel methodologies play a powerful role in improving patient outcomes. The Third Transatlantic Exchange in Oncology, led by thought leaders from Dana-Farber Cancer Institute and Gustave Roussy with the support of L’Institut Servier, examines the utility of liquid biopsy as a window into oncogenic activity across the disease pathway for a multitude of cancers. Join us in Boston or via our virtual platform to learn how innovations in the lab are helping to solve important challenges in the clinic.

Faculty

agenda

April 12, 2024

08:00 – 08:20 AM | Opening and Welcome Toni K Choueiri, MD (Program Chair, Moderator)
Karim Fizazi, MD, PhD (Program Chair, Moderator)
Kevin Haigis, PhD
Fabrice Barlesi, MD, PhD